Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
N83RT83R's Profile
Displaying 1-2 of 2 result(s).
VERB Verb Technology Company, Inc
09/18/2021 5:14:11 PM
Wow thanks for the informative resp (9)
VERB Verb Technology Company, Inc
09/18/2021 8:02:40 AM
http://investorshangout.com/images (10)

Recent Articles

  • Yili Triumphs with Four Awards at Global Dairy Innovation Event
  • Novartis Completes HSR Waiting Period for Regulus Acquisition
  • Idorsia's QUVIVIQ Gains Approval for China Market Expansion
  • Significant Changes in EPH European Property Holdings' Ownership
  • Sarclisa Gains Ground with Positive CHMP Opinion for Approval
  • Promising Progress of Roche's NXT007 in Hemophilia A Treatment
  • SBC Medical Strengthens Investor Relations Through Conferences
  • Discover Summer Wonders in Morocco with Wego's New Campaign
  • ICEYE's Strategic Partnership Boosts Netherlands Air Force ISR Tech
  • APP Group Showcases Innovations for Sustainable Packaging Growth
  • ICEYE Partners with Royal Netherlands Air Force for ISR Solutions
  • HONGQI's Golden Sunflower Series Shines at Global Auto Expo
  • Vooglam Elevates Festival Fashion with Interactive Eyewear
  • Kinterra Capital Proposes to Acquire New World Resources Equity
  • Blockchain Alliance International Champions Asia-Pacific Growth
  • Risen Energy's Commitment to Sustainable Manufacturing and ESG
  • Risen Energy's Commitment to Sustainability in ESG Practices
  • Minjee Lee Shines at KPMG Women's PGA with Callaway Gear
  • Promising Results of Equecabtagene Autoleucel in MS Therapy
  • Explore ZA Miner's Exciting Offerings in Cloud Mining
  • Global Collaboration to Revolutionize Treatment of Autoimmune Diseases
  • Treeline Global Launches Revolutionary 25-Year Scientific Venture
  • New Study Links Nightmares to Early Death and Aging Process
  • Impact of Nightmares on Lifespan and Biological Aging Revealed
  • Enhancing Heart Health: Oral Semaglutide for Diabetes Patients
  • Molecular Partners Advances MP0726 with Orano Med Collaboration
  • Mim8 Treatment for Haemophilia A: Promising Phase 3 Findings
  • Mim8 Brings New Hope for Hemophilia A Patients: Study Insights
  • Once-Weekly Insulin Efsitora Shows Promising Outcomes for Diabetes
  • Innovative Inhaled Insulin Offers New Hope for Young Diabetics
  • Lilly's Efsitora Alfa Offers Innovative Diabetes Treatment Solution
  • Innovative Research Sheds Light on Uterine Cancer Treatment Paths
  • Investigation of Luminar Technologies: What Investors Should Know
  • Investigation Launched into Travere Therapeutics' Practices
  • Meta Platforms Faces Investigation: Implications for Investors
  • Investigation Launched into ADTRAN Holdings, Inc. (ADTN)
  • Class Action Filed Against Red Cat Holdings, Inc. Over Securities
  • Investigation on NeuroPace, Inc.: Protecting Investor Interests
  • Investigation Launched into Groupon, Inc. - Discover the Details
  • Understanding the Class Action Lawsuit Against Broadmark Realty Capital
  • PTC Therapeutics Faces Scrutiny Amid Growing Investor Concerns
  • Starbucks Faces Lawsuit Over Alleged Labor Code Violations
  • Unleashing Daring Challenges: Explore Cajole's Unique Ventures
  • Oklahoma City Mayor David Holt Leads New Era for Cities
  • Opportunities for Investors in Rocket Pharmaceuticals Class Action
  • FinThrive Unveils Agentic AI Technology for Revenue Cycle Success
  • Monster Energy Athletes Shine at X Games Osaka, Making History
  • Reckitt Benckiser Group Faces Class Action Lawsuit from Investors
  • Investigation of Investor Claims Against Sanofi - SNY Alert
  • Investigation Issued for NWTN Inc. Investors: Key Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site